KHADIJAT OKASIME: Open Payments
NPI 1659034155 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,403 in 57 payments from 11 companies in 2025. Trend: 2023 $1,151 · 2024 $1,662 · 2025 $2,403
Food & beverage: $2,403
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $840 |
| Janssen Biotech, Inc. | 11 | $607 |
| Madrigal Pharmaceuticals | 3 | $240 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $144 |
| Ardelyx, Inc. | 3 | $136 |
| Gilead Sciences, Inc. | 1 | $125 |
| PFIZER INC. | 1 | $105 |
| QOL Medical, LLC | 1 | $95 |
| Medtronic, Inc. | 1 | $85 |
| Amgen Inc. | 1 | $16 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, SKYRIZI, IBSRELA, Livdelzi, MAVYRET, ENTYVIO.
Industry payments across PA — which companies pay providers there.
